Journal Article Summary
The article examines the prescribing patterns of antihypertensive medications for children in China from 2018 to 2021, highlighting the importance of understanding how hypertension is managed in this population. Pediatric hypertension is increasingly recognized as a precursor to cardiovascular diseases, yet there is limited knowledge about the actual use of antihypertensive drugs in children. This study aims to fill that gap by providing insights into the epidemiological characteristics of pediatric hypertension and the adherence to treatment guidelines in real-world settings.
The researchers conducted a cross-sectional study analyzing prescription data from 127 hospitals across nine major cities in China, collecting information on 1,301 prescriptions for children diagnosed with hypertension. They found that the average number of antihypertensive drugs per prescription was 1.45, with calcium channel blockers (CCBs), angiotensin II receptor blockers (ARBs), and beta-blockers (BBs) being the most commonly prescribed medications. Notably, only 14.20% of the prescribed drugs were in line with the Chinese guidelines for hypertension treatment, raising concerns about the rational use of these medications in children.
Despite the study's comprehensive approach, there are limitations that should be considered. The data may not fully represent the prescribing practices across all of China, as it was sourced from a specific database, and the sample size for pediatric prescriptions was relatively small. Additionally, the retrospective nature of the study means that follow-up data on treatment outcomes and patient adherence were not available. Readers are encouraged to discuss any concerns about hypertension management in children with healthcare professionals, especially regarding the appropriateness of prescribed medications and adherence to treatment guidelines.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Qian Qin, Wang Yu-Zhen, Kan Lian-Di, Chen Jie, Wang Chen, Han Gang, Li Liu-Cheng, Lou Wei-Jian. Real-World Prescribing Patterns for Hypertensive Children in China from 2018 to 2021: A Cross-Sectional Multicenter Study. Risk Management and Healthcare Policy 2023. DOI: 10.2147/RMHP.S392224. PMID: 36875172. PMCID: PMC9983439.
Featured Pill Pals Product
Terazosin 2 mg Capsules --- Generic For Hytrin --- Avet
Terazosin 2 mg Capsules — Generic For Hytrin — Avet is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
